Soc. Generale Call 30 ML 20.09.20.../ DE000SW1ZST8 /
30/05/2024 08:12:13 | Var.0.000 | Denaro22:00:38 | Lettera22:00:38 | Sottostante | Prezzo di esercizio | Expiration date | Tipo di opzione |
---|---|---|---|---|---|---|---|
0.700EUR | 0.00% | - Quantità in denaro: - |
- Quantità in lettera: - |
Cie Generale des Eta... | 30.00 EUR | 20/09/2024 | Call |
GlobeNewswire
22:51
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a R...
GlobeNewswire
22:50
BiomX Inc. Receives Notice of Non-Compliance with NYSE American Continued Listing Standards
GlobeNewswire
22:47
Favorable Oncocyte VitaGraft Kidney Study Results Published in the New England Journal of Medicine
GlobeNewswire
22:38
Culinary Tours partners with Tennis Channel to create French-inspired recipes for French Open
GlobeNewswire
22:30
American Lithium Announces Financial and Operating Highlights for Year and Quarter Ended February 29...
GlobeNewswire
22:30
Ispire Technology Inc. to Present at the KCSA Cannabis Virtual Investor Conference June 5th
GlobeNewswire
22:30
Dianthus Therapeutics to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
22:30
HOOKIPA Pharma to Host Investor Call on HB-200 Data Presented at American Society of Clinical Oncolo...
GlobeNewswire
22:30
Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
GlobeNewswire
22:25
Supernus Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference